Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News CASI Pharmaceuticals Inc CASI

Healthcare Biotechnology
CASI Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company is focused on acquiring, developing, and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. Its... see more

Recent & Breaking News (NDAQ:CASI)

CASI Pharmaceuticals Announces Second Quarter and First Half 2019 Financial and Business Results

PR Newswire August 9, 2019

CASI Pharmaceuticals Acquires Worldwide Rights To Commercialize anti-CD19 T-cell Therapy

PR Newswire June 17, 2019

CASI Pharmaceuticals To Present At The 2019 BIO International Convention

PR Newswire June 3, 2019

CASI Pharmaceuticals Announces First Quarter 2019 Financial and Business Results

PR Newswire May 15, 2019

INVESTOR ALERT: Monteverde & Associates PC Launches an Investigation of the Board of Directors and Officers

PR Newswire April 18, 2019

CASI Pharmaceuticals In-Licenses Exclusive Worldwide Rights to Novel Anti-CD38 Monoclonal Antibody Program From Black Belt Therapeutics

PR Newswire April 17, 2019

CASI Pharmaceuticals Announces The Appointment Of Wei-Wu He, Ph.D., Executive Chairman, To The Role Of Chief Executive Officer

PR Newswire April 2, 2019

CASI Pharmaceuticals Announces Fourth Quarter And Full Year 2018 Financial Results And Business Results

PR Newswire March 29, 2019

CASI Pharmaceuticals Announces Exclusive Distribution Partner For Melphalan Hydrochloride For Injection (EVOMELA®) In China

PR Newswire March 13, 2019

CASI Pharmaceuticals Announces China National Medical Products Administration (NMPA) Approval Of CTA To Conduct Registration Trial For MARQIBO®

PR Newswire March 7, 2019

CASI Pharmaceuticals Announces China National Medical Products Administration (NMPA) Approval Of CTA To Conduct Confirmatory Clinical Trial For ZEVALIN®

PR Newswire February 19, 2019

CASI Pharmaceuticals to Present at the BIO CEO & Investor Conference

PR Newswire February 6, 2019

CASI Pharmaceuticals Announces China Market Approval Of Melphalan Hydrochloride For Injection (Trademark: EVOMELA®)

PR Newswire December 3, 2018

Report: Exploring Fundamental Drivers Behind CASI Pharmaceuticals, Booking, Enstar Group, Madrigal Pharmaceuticals, Dermira, and Kaiser Aluminum — New Horizons, Emerging Trends, and Upcoming Developments

GlobeNewswire November 28, 2018

CASI Pharmaceuticals To Build GMP Manufacturing Site In Wuxi, China

PR Newswire November 16, 2018

CASI Pharmaceuticals Announces Third Quarter and First Nine Months 2018 Financial and Business Results

PR Newswire November 14, 2018

CASI Pharmaceuticals Acquires HBV ANDA from Laurus Labs Limited

PR Newswire October 23, 2018

CASI Pharmaceuticals Announces Appointment Of President To Its China Operations To Lead Commercialization

PR Newswire October 2, 2018

CASI Pharmaceuticals Announces Appointment Of Chief Financial Officer

PR Newswire September 28, 2018

CASI Pharmaceuticals Announces $48.5 Million Private Placement

PR Newswire September 14, 2018